Watchlist Price Alert

Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · Real-Time Price · USD

0.34

0.01 (2.16%)

At close: Jun 06, 2025, 1:44 PM

Oncolytics Biotech Income Statement

Financials in CAD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	403K	392K	452.06K	446.19K	485.57K	95.38K	90.77K	162.23K
Gross Profit	-403K	-392K	-452.06K	-446.19K	-485.57K	-95.38K	-90.77K	-162.23K
Operating Income	-33.79M	-28.57M	-26.23M	-25.46M	-20.69M	-16.66M	-15.61M	-15.29M
Interest Income	1.33M	528K	98.61K	121.19K	179.28K	173.5K	130.1K	163.9K
Pretax Income	-27.66M	-24.75M	-26.25M	-22.51M	-33.12M	-16.49M	-15.48M	-15.13M
Net Income	-27.75M	-24.84M	-26.3M	-19.55M	-45.55M	-17.04M	-15.62M	-15.14M
Selling & General & Admin	16.08M	11.49M	12.86M	12.07M	8.84M	7.08M	6.21M	5.36M
Research & Development	17.71M	15.43M	12.92M	12.94M	11.13M	9.42M	9.39M	9.77M
Other Expenses	n/a	n/a	13.31M	12.51M	9.56M	7.24M	6.21M	162.23K
Operating Expenses	33.79M	26.92M	26.23M	25.46M	20.69M	16.66M	15.61M	15.29M
Interest Expense	n/a	528K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	-452.49K	-445.69K	n/a	n/a	n/a	n/a
Cost & Expenses	33.79M	26.92M	26.23M	25.46M	20.69M	16.66M	15.61M	15.29M
Income Tax Expense	97K	84K	49.43K	-2.95M	12.43M	548.04K	141.5K	9.37K
Shares Outstanding (Basic)	67.62M	58.03M	53.51M	40.34M	22.14M	16.02M	13.94M	12.62M
Shares Outstanding (Diluted)	67.62M	58.03M	53.51M	40.34M	22.14M	16.02M	13.94M	12.62M
EPS (Basic)	-0.41	-0.43	-0.49	-0.48	-2.06	-1.06	-1.12	-1.2
EPS (Diluted)	-0.41	-0.43	-0.49	-0.48	-2.06	-1.06	-1.12	-1.2
EBITDA	-33.71M	-26.83M	-25.66M	-25.37M	-20.02M	-17.18M	-15.51M	-15.13M
EBIT	-33.79M	-26.92M	-26.23M	-25.46M	-20.14M	-17.27M	-14.83M	-13.96M
Depreciation & Amortization	81K	392K	452.06K	446.19K	485.57K	95.38K	90.77K	162.23K